ESTIMATING THE IMPACT OF DELAYED TREATMENT FOR MAJOR DEPRESSIVE DISORDER USING A CONTINUOUSTIME PATIENT-LEVEL SIMULATION MODEL

被引：0
|
作者：
Chapman, R. [1 ]
Cheng, M. [1 ]
Xie, R. [2 ]
机构：
[1] Innovat & Value Initiat, Alexandria, VA USA
[2] RA Capital Management, Newton, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE501
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [41] COMPARING THE USE OF PATIENT-LEVEL DATA TO AN AVERAGE PATIENT PROFILE WITHIN A TYPE 2 DIABETES SIMULATION MODEL
    McEwan, P.
    Bennett, H.
    Ward, T.
    Bergenheim, K.
    VALUE IN HEALTH, 2014, 17 (07) : A546 - A546
  • [42] The Patient Perspective: Esketamine Treatment for Major Depressive Disorder With Active Suicidal Ideation and Intent
    Jamieson, Carol
    Fu, Dong-Jing
    Ionescu, Dawn
    Lane, Rosanne
    Canuso, Carla
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 222 - 222
  • [43] A DISCRETE CHOICE EXPERIMENT OF PATIENT-INFORMED PREFERENCES FOR MAJOR DEPRESSIVE DISORDER TREATMENT
    Dosreis, S.
    Amill-Rosario, A.
    Ali, C.
    Elonge, E.
    Xie, R.
    Chapman, R.
    Slejko, J. F.
    VALUE IN HEALTH, 2022, 25 (07) : S299 - S299
  • [44] Lamotrigine Induces Hair Loss in a Patient With Treatment-Resistant Major Depressive Disorder
    Solmi, Marco
    Tamiello, Gianni Ivo
    Manuli, Giuseppe
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (05) : E611 - E612
  • [45] A CASE OF SUCCESSFUL KETAMINE TREATMENT AFTER ECT FAILURE IN A PATIENT WITH MAJOR DEPRESSIVE DISORDER
    Chatham, Anthony
    Deppe, John
    Subler, Ashley
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (04): : S25 - S25
  • [46] Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
    Oluboka, Oloruntoba J.
    Katzman, Martin A.
    Habert, Jeffrey
    McIntosh, Diane
    MacQueen, Glenda M.
    Milev, Roumen V.
    McIntyre, Roger S.
    Blier, Pierre
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (02): : 128 - 144
  • [47] An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression
    Wu, Bingcao
    Cai, Qian
    Sheehan, John J.
    Benson, Carmela
    Connolly, Nancy
    Alphs, Larry
    PLOS ONE, 2019, 14 (08):
  • [48] Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies
    Crisanti, Camilla
    Enrico, Paolo
    Fiorentini, Alessio
    Delvecchio, Giuseppe
    Brambilla, Paolo
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 1109 - 1118
  • [49] Do comorbid anxiety disorders impact treatment planning for outpatients with major depressive disorder?
    Petersen, Timothy
    Andreotti, Charissa F.
    Chelminski, Iwona
    Young, Diane
    Zimmerman, Mark
    PSYCHIATRY RESEARCH, 2009, 169 (01) : 7 - 11
  • [50] Preferences for Treatments for Major Depressive Disorder: Formative Qualitative Research Using the Patient Experience
    Susan dosReis
    Laura M. Bozzi
    Beverly Butler
    Richard Z. Xie
    Richard H. Chapman
    Jennifer Bright
    Erica Malik
    Julia F. Slejko
    The Patient - Patient-Centered Outcomes Research, 2023, 16 : 57 - 66
12345